Vanessa Rangel Miller, MS, MBA, CGC is Executive Director of Molecular Diagnostics Programs within Global Medical Affairs at Ultragenyx Pharmaceutical Inc. She was previously at Invitae, where she worked in Biopharma/Advocacy Business Development, after leading the Patient Insights Network (patient registry) programs. Prior to Invitae, she co-founded PatientCrossroads (d.b.a. AltaVoice), where she brought together genetics, technology, and academic partners in forming patient registries for rare and common conditions. Vanessa is a certified genetic counselor and has previously worked for Emory University as a laboratory and clinical genetic counselor. She currently serves on the Board of the Cure GM1 Foundation.
